Sort
51,593 grants matching “hepatitis”
Cancer stem cells and human liver cancer
$374,580Snorri Thorgeirsson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Comparative Functional Genomics: Identifying Best-fit Models for Human Cancers
$374,580Snorri S Thorgeirsson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Targeting proteotoxic stress responses in liver fibrosis
$374,571Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 7/9
$374,552Ramon Bataller · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AA
Harvard Hepatitis B Consortium
$374,534Daryl T Lau · Beth Israel Deaconess Medical Center · U01 · FY2009 · DK
Mechanisms of Hepatitis B Virus Replication
$374,531Daniel D Loeb · University Of Wisconsin-Madison · P01 · FY2009 · CA
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS
$374,514Medical College Of Wisconsin · R01 · FY2003 · AI
Targeting proteotoxic stress responses in liver fibrosis
$374,513Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AA
Insulin resistance in the pathogenesis of NASH
$374,500Sonia Michael Najjar · University Of Toledo Health Sci Campus · R01 · FY2009 · DK
Genetics of Hypertension
$374,500Ashok Kumar Kumar · University Of Toledo Health Sci Campus · R01 · FY2012 · HL
Insulin resistance in the pathogenesis of NASH
$374,500Sonia Michael Najjar · University Of Toledo Health Sci Campus · R01 · FY2010 · DK
Genetic Regulation of the Hepatic Acute Phase Response
$374,495Roswell Park Cancer Institute Corp · R01 · FY2004 · DK
A Novel Role for Vasopressin in Fructose-Induced Metabolic Syndrome
$374,482Miguel Angel Lanaspa Garcia · Oregon Health & Science University · R01 · FY2022 · DK
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$374,436Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2022 · CA
Clinical Core
$374,431John A Bartlett · Duke University · P30 · FY2022 · AI
REGULATION OF HEPATIC GLUCOSE FLUXES
$374,424Yeshiva University · R01 · FY2003 · DK
GMPS-GMPR axis melanoma progression and therapy
$374,421Mikhail Nikiforov · Wake Forest University Health Sciences · R01 · FY2021 · CA
Michigan Hepatotoxicity Clinical Research Network Renewal
$374,400Robert J Fontana · University Of Michigan At Ann Arbor · U01 · FY2024 · DK
THE ROLE OF HEPATOKINE ORM2 IN ADIPOSE TISSUE INFLAMMATION
$374,400Kangho Kim · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DK
Alcohol and Monocyte Signaling
$374,385Gyongyi Szabo · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · AA
Targeting Shc to reduce inflammation and fibrosis in the aging liver
$374,324Natalie J Torok · Palo Alto Veterans Instit For Research · R01 · FY2020 · AG
Mechanisms of Obesity and Its Metabolic Complications in Youth.
$374,322Nicola Santoro · Yale University · R01 · FY2020 · DK
Core C: Cardiovascular Pathology Core
$374,313Timothy E O'Toole · American Heart Association · P50 · FY2017 · HL
RFA-IP20-003: Individual-based Simulation of Seasonal and Pandemic Influenza Epidemics - supplement Emergency Response to the COVID-19 Pandemic
$374,274Mark Stenius Roberts · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · IP
TRANSLOCATION, ASSEMBLY, AND DEGRADATION OF APOB
$374,264Beth Israel Deaconess Medical Center · R01 · FY2002 · HL